Journal list Promote Sponsor
verified SJR 0,688 · Q2 • database Scopus / SJR & Web of Science indexed
European Journal of Contraception and Reproductive Health Care
United Kingdom · Informa Healthcare
workspace_premium Q2 — Medicine (miscellaneous) lock Subscription

European Journal of Contraception and Reproductive Health Care

European Journal of Contraception and Reproductive Health Care is a journal indexed in SJR in Medicine (miscellaneous) and Obstetrics and Gynecology with an H index of 55. It has a price of 2990 €. It has an SJR impact factor of 0,688 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,688.

ISSN: 1362-5187
Publisher: Informa Healthcare
Category: Medicine (miscellaneous)
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
0,688 Q2
H-index 55
Acceptance rate pie_chart
31%
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
2.990 € Subscription
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,688

H-index

55

Docs (year)

44

Docs 3y

200

Total refs

1434

Cites 3y

357

Citable 3y

185

Cites/Doc 2y

1.74

Ref/Doc

32.59

Immediate OA

2990 €

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Assessment of spermicidal activity of the antimicrobial peptide sarcotoxin Pd: A potent contraceptive agent

View more

Young people benefit from comprehensive education on reproductive health

View more

Contraceptive use, fertility, and unsafe abortion in developing countries

View more

Contraception, reproductive health and pregnancy outcomes among women exposed to intimate partner violence in Nigeria

View more

Contraception in the Spanish press: An analysis of the 1997-2002 period

View more

Consumption of combined oral contraceptives and venous thromboembolism in Zagreb, Croatia

View more

Combined ethinylestradiol/gestodene contraceptive patch: two-center, open-label study of ovulation inhibition, acceptability and safety over two cycles in female volunteers

View more

College students in Nigeria underestimate their risk of contracting HIV/AIDS infection

View more

Clinical profile of contraceptive progestins

View more

Characteristics of women at low risk of STI presenting with pelvic inflammatory disease

View more

CanPorphyromonas gingivalisbe a novel aetiology for recurrent miscarriage?

View more

Brave and angry -The creation and development of the International Planned Parenthood Federation (IPPF)

View more
SHOW MORE ARTICLES

Bacterial species present in the lower male genital tract: A five-year retrospective study

View more

50th Anniversary of the pill -What does this story teach us?

View more

Age at menarche in Turkish adolescents in Kahramanmaras, Eastern Mediterranean region of Turkey

View more

After 50 years of ethinylestradiol, another oestrogen in combined oral contraceptives

View more

Adolescent access to emergency contraception: a comment on the UK context

View more

Acoustic measures of vocal stability during different speech tasks in young women using oral contraceptives: a retrospective study

View more

Access to contraceptive services among unmarried young people in the north-east of China

View more

Acceptability of intrauterine contraception among women living with human immunodeficiency virus: a randomised clinical trial

View more

Acceptability and side-effects of Implanon in Switzerland: a retrospective study by the Implanon Swiss Study Group

View more

A Plea For Male Contraception

View more

A pharmacokinetic study with a low-dose oral contraceptive containing 20 µg ethinylestradiol plus 100 µg levonorgestrel

View more

A novel hysteroscopic hook for extracting retained contraceptive intrauterine devices under direct vision

View more

FAQs